CN105037553B - 一种能够检测癌症的免疫球蛋白 - Google Patents
一种能够检测癌症的免疫球蛋白 Download PDFInfo
- Publication number
- CN105037553B CN105037553B CN201510513565.4A CN201510513565A CN105037553B CN 105037553 B CN105037553 B CN 105037553B CN 201510513565 A CN201510513565 A CN 201510513565A CN 105037553 B CN105037553 B CN 105037553B
- Authority
- CN
- China
- Prior art keywords
- seq
- cdr3
- cdr1
- mmp9
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
人MMP1 | 人MMP2 | 小鼠MMP2 | 人类MMP3 | 人类MMP7 | 人类MMP8 | 人类MMP9 | 猕猴MMP9 | 小鼠MMP9 | 大鼠MMP9 | 人类MMP10 | 人类MMP12 | 人类MMP13 | |
MMP9-1 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.14nM | 0.16nM | >100nM | 0.35nM | >100nM | >100nM | >100nM |
MMP9-2 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-3 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.02nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-4 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-5 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.04nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-6 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-7 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.02nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-8 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-9 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.02nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-10 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-11 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.04nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-12 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.02nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-13 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-14 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.03nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-15 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.02nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
MMP9-16 | >100nM | >100nM | >100nM | >100nM | >100nM | >100nM | 0.04nM | >40nM | >100nM | >60nM | >100nM | >100nM | >100nM |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510513565.4A CN105037553B (zh) | 2015-08-20 | 2015-08-20 | 一种能够检测癌症的免疫球蛋白 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510513565.4A CN105037553B (zh) | 2015-08-20 | 2015-08-20 | 一种能够检测癌症的免疫球蛋白 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105037553A CN105037553A (zh) | 2015-11-11 |
CN105037553B true CN105037553B (zh) | 2018-04-17 |
Family
ID=54444557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510513565.4A Active CN105037553B (zh) | 2015-08-20 | 2015-08-20 | 一种能够检测癌症的免疫球蛋白 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105037553B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108277214B (zh) * | 2018-02-23 | 2021-07-06 | 广东医科大学 | 一种应激磷酸化抗原多肽、抗体、制备方法以及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103140240A (zh) * | 2010-08-27 | 2013-06-05 | 吉联亚生物科技有限公司 | 基质金属蛋白酶9的抗体 |
WO2013130078A1 (en) * | 2012-02-29 | 2013-09-06 | Gilead Biologics, Inc. | Antibodies to matrix metalloproteinase 9 |
WO2013188846A1 (en) * | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions |
-
2015
- 2015-08-20 CN CN201510513565.4A patent/CN105037553B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103140240A (zh) * | 2010-08-27 | 2013-06-05 | 吉联亚生物科技有限公司 | 基质金属蛋白酶9的抗体 |
CN104530238A (zh) * | 2010-08-27 | 2015-04-22 | 吉联亚生物科技有限公司 | 基质金属蛋白酶9的抗体 |
WO2013130078A1 (en) * | 2012-02-29 | 2013-09-06 | Gilead Biologics, Inc. | Antibodies to matrix metalloproteinase 9 |
WO2013188846A1 (en) * | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions |
Also Published As
Publication number | Publication date |
---|---|
CN105037553A (zh) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Watanabe et al. | Antibodies to a conserved influenza head interface epitope protect by an IgG subtype-dependent mechanism | |
de Marco | Biotechnological applications of recombinant single-domain antibody fragments | |
CN102652139B (zh) | Pcsk9拮抗剂 | |
HRP20192280T1 (hr) | Anti-ceacam6 protutijela i njihova uporaba | |
US10703802B2 (en) | Composition comprising at least two influenza A virus-neutralizing-binding molecules | |
JP6437913B2 (ja) | 複合体特異的抗体及び抗体断片並びにその使用 | |
Phillips et al. | Rate of asparagine deamidation in a monoclonal antibody correlating with hydrogen exchange rate at adjacent downstream residues | |
CN109071637B (zh) | 结合严重发热伴血小板减少综合征病毒的包膜糖蛋白的抗体及其用途 | |
EP2762491B1 (en) | Binding molecule having influenza a virus-neutralizing activity produced from human b cell | |
RU2635999C2 (ru) | Антитела, подходящие для пассивной иммунизации против гриппа | |
JP2018121657A5 (zh) | ||
CN103562227A (zh) | Pcsk9拮抗剂 | |
RU2668802C2 (ru) | Антитела, используемые для пассивной вакцинации против гриппа | |
JP2014511179A5 (zh) | ||
JP2013518903A5 (zh) | ||
JP2017537082A5 (zh) | ||
CN107207587A (zh) | 人源化抗‑补体因子c1q抗体及其应用 | |
AU2012205663A1 (en) | Antibodies directed against influenza | |
JP2011509245A5 (zh) | ||
WO2003006509A3 (en) | Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor | |
Yeung et al. | Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire | |
WO2015131836A1 (zh) | 一种h7型甲型流感病毒的中和抗体及其用途 | |
CN109206516A (zh) | 抗IL-23p19抗体 | |
CA2786479A1 (en) | Methods for treating pancreatic cancer | |
WO2014186728A2 (en) | Methods for diagnosing and treating inflammatory bowel disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Tian Chunyan Inventor after: Li Jing Inventor before: Li Jing |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180328 Address after: C24-114 Island District waters 028000 economic and Technological Development Zone Tongliao city the Inner Mongolia Autonomous Region Applicant after: Inner Mongolia Meng Yuan Biological Gene Technology Co., Ltd. Address before: 457000 Puyang City Changqing Road and Subei Road intersection drilling two company training and assessment station in Henan Applicant before: Li Jing |
|
TA01 | Transfer of patent application right |